Noyce, Alastair J.

Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study

Schrag, A., Horsfall, L., Walters, K., Noyce, A., & Petersen, I. (2015) · The Lancet Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 674

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study

De Pablo-Fernandez, E., Goldacre, R., Pakpoor, J., Noyce, A. J., & Warner, T. T. (2018) · Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 242

Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression

Chohan, H., Senkevich, K., Patel, R. K., Bestwick, J. P., Jacobs, B. M., Bandres Ciga, S., Gan‐Or, Z., & Noyce, A. J. (2021) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 228

Constipation preceding Parkinson's disease: a systematic review and meta-analysis

Adams-Carr, K. L., Bestwick, J. P., Shribman, S., Lees, A., Schrag, A., & Noyce, A. J. (2016) · Journal of Neurology, Neurosurgery & Psychiatry

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 228

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

Nalls, M. A., McLean, C. Y., Rick, J., Eberly, S., Hutten, S. J., Gwinn, K., Sutherland, M., Martinez, M., Heutink, P., Williams, N. M., et al. (2015) · The Lancet Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 204

Infection and Risk of Parkinson’s Disease

Smeyne, R. J., Noyce, A. J., Byrne, M., Savica, R., & Marras, C. (2021) · Journal of Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 125

Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease

Jensen, M. P., Jacobs, B. M., Dobson, R., Bandres‐Ciga, S., Blauwendraat, C., Schrag, A., Noyce, A. J., & The International Parkinson's Disease Genomics Consortium (IPDGC) (2021) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 91

Additional rare variant analysis in Parkinson’s disease cases with and without known pathogenic mutations: Evidence for oligogenic inheritance

Lubbe, S. J., Escott-Price, V., Gibbs, J. R., Nalls, M. A., Bras, J., Price, T. R., Nicolas, A., Jansen, I. E., Mok, K. Y., Pittman, A. M., et al. (2016) · Human Molecular Genetics

Parkinson's Disease Mechanisms and TreatmentsLysosomal Storage Disorders Research

Cited by 61

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics

Magdalinou, N. K., Noyce, A. J., Pinto, R., Lindstrom, E., Holmén-Larsson, J., Holtta, M., Blennow, K., Morris, H. R., Skillbäck, T., Warner, T. T., et al. (2017) · Parkinsonism & Related Disorders

Parkinson's Disease Mechanisms and TreatmentsAdvanced Proteomics Techniques and Applications

Cited by 49